Ocumetics Technology Corp (TSE:OTC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Ocumetics Technology Corp. has identified potential improvements in its accommodative intraocular lens design during internal tests, which could enhance performance and safety. The company will re-manufacture the lenses, causing a 45 to 60-day delay in its first human trials, but believes these enhancements will set new industry benchmarks.
For further insights into TSE:OTC stock, check out TipRanks’ Stock Analysis page.